4.7 Review

Challenges of Stem Cell Therapy for Spinal Cord Injury: Human Embryonic Stem Cells, Endogenous Neural Stem Cells, or Induced Pluripotent Stem Cells?

Journal

STEM CELLS
Volume 28, Issue 1, Pages 93-99

Publisher

WILEY
DOI: 10.1002/stem.253

Keywords

embryonic stem cells; iPS cells; stem cell therapy; spinal cord

Funding

  1. Regional Government Health Department
  2. Spanish Ministry of Health
  3. Spanish Ministry of Science and Innovation [SAF2007-63193]
  4. La Marato [TV3 070330]

Ask authors/readers for more resources

Spinal cord injury (SCI) causes myelopathy, damage to white matter, and myelinated fiber tracts that carry sensation and motor signals to and from the brain. The gray matter damage causes segmental losses of interneurons and motoneurons and restricts therapeutic options. Recent advances in stem cell biology, neural injury, and repair, and the progress toward development of neuroprotective and regenerative interventions are the basis for increased optimism. This review summarizes the pathophysiological mechanisms following SCI and compares human embryonic, adult neural, and the induced pluripotent stem cell-based therapeutic strategies for SCI. STEMCELLS 2010; 28: 93

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available